Literature DB >> 7447527

Analysis of Twenty-three plasma proteins in ascites. The depletion of fibrinogen and plasminogen.

J M Henderson, S F Stein, M Kutner, M B Wiles, J D Ansley, D Rudman.   

Abstract

The concentrations of 23 plasma proteins were measured by radial immunodiffusion in the plasma and ascites of 17 patients with cirrhosis and four patients with intraperitoneal malignancies, to learn whether there is a selectivity in the movement of proteins from plasma into ascites, analogous to that of proteinuria. Additionally, since some of the proteins are involved in coagulation, we hoped to clarify the coagulopathy frequently seen following peritoneovenous shunting of ascites. Analysis was by groups: group 1 consisted of nine patients with cirrhosis with an ascites-total protein content less than 2.5 g/dl; group 2 consisted of eight patients with cirrhosis with ascites-total protein content greater than or equal to 2.5 g/dl; and group 3 consisted of four patients with malignant ascites. The ratio of the plasma concentration/ascites concentration ([P]/[A]) for each protein was calculated for each patient. In each group the median [P]/[A] for each protein was plotted against the natural logarithm of its molecular weight (In MW). For 21 of the 23 proteins, [P]/[A] showed a close linear relationship to In MW. Fibrogen and plasminogen showed significant (p < 0.0002) elevation above the regression line relating [P]/[A] to In MW. This indicates depletion of fibrinogen and plasminogen in ascites. The ascites in group 1 showed moderate selectivity, defined as the slope of the regression line (1.59), while groups 2 and 3 were essentialy nonselective (0.35 and 0.50). Fibrin-split products were elevated in all ascites but not in plasma, indicating either fibrinolysis or fibrinogenolysis within the ascites. A normal ratio for prothrombin suggests fibrinogenolysis may be the dominant mechanism. Thus the coagulopathy induced by LeVeen valve insertion may be in part secondary to the infusion of plasmin or a plasminogen activator into the circulation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447527      PMCID: PMC1344973          DOI: 10.1097/00000658-198012000-00008

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  12 in total

1.  SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME.

Authors:  G R JOACHIM; J S CAMERON; M SCHWARTZ; E L BECKER
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

2.  Ascites. I. The value of examination of ascitic fluid and blood for lipids and for proteins by electrophoresis.

Authors:  R A ROVELSTAD; L G BARTHOLOMEW; J C CAIN; B F McKENZIE; E H SOULE
Journal:  Gastroenterology       Date:  1958-03       Impact factor: 22.682

3.  The simple assessment of selectivity in heavy proteinuria.

Authors:  J S Cameron; G Blandford
Journal:  Lancet       Date:  1966-07-30       Impact factor: 79.321

4.  High protein ascites in patients with uncomplicated hepatic cirrhosis.

Authors:  R E Sampliner; F L Iber
Journal:  Am J Med Sci       Date:  1974-05       Impact factor: 2.378

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites.

Authors:  J D Ansley; R A Bethel; P A Bowen; W D Warren
Journal:  Surgery       Date:  1978-02       Impact factor: 3.982

7.  Protein selectivity in the assessment of patients with proteinuria.

Authors:  J J Petrie; P R MacLean; J S Robson
Journal:  Aust N Z J Med       Date:  1973-10

8.  Complications after peritoneovenous shunting for ascites.

Authors:  P D Greig; B Langer; L M Blendis; B R Taylor; M F Glynn
Journal:  Am J Surg       Date:  1980-01       Impact factor: 2.565

9.  Fatal disseminated intravascular coagulation after peritoneovenous shunt for intractable ascites.

Authors:  J W Matseshe; R W Beart; L G Bartholomew; W P Baldus
Journal:  Mayo Clin Proc       Date:  1978-08       Impact factor: 7.616

10.  Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts.

Authors:  R G Lerner; J C Nelson; P Corines; L R del Guercio
Journal:  JAMA       Date:  1978-11-03       Impact factor: 56.272

View more
  15 in total

Review 1.  [Peritoneovenous shunt in the treatment of therapy-refractory ascites].

Authors:  C A Eriksen; A Cuschieri
Journal:  Langenbecks Arch Chir       Date:  1988

2.  Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunting for ascites. An autopsy study with clinical correlations.

Authors:  M M Stanley; C V Reyes; H B Greenlee; B Nemchausky; G F Reinhardt
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

3.  Ascitic fluid alpha 1-antitrypsin.

Authors:  F G Villamil; P B Sorroche; H F Aziz; P M Lopez; J M Oyhamburu
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

4.  Coagulopathy post peritoneovenous shunt.

Authors:  H H LeVeen; M Ip; N Ahmed; R B Hutto; E G LeVeen
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

5.  A Metabolomic Analysis of Cirrhotic Ascites.

Authors:  Diren Beyoğlu; Cedric Simillion; Federico Storni; Andrea De Gottardi; Jeffrey R Idle
Journal:  Molecules       Date:  2022-06-20       Impact factor: 4.927

Review 6.  Fibrinolytic activity of ascites caused by alcoholic cirrhosis and peritoneal malignancy.

Authors:  D M Scott-Coombes; S A Whawell; M N Vipond; L Crnojevic; J N Thompson
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Ascites-induced LeVeen shunt coagulopathy.

Authors:  M V Ragni; J H Lewis; J A Spero
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

8.  Hemostatic Findings in Ascitic Fluid: A Cross-Sectional Study in 70 Dogs.

Authors:  A Zoia; M Drigo; C J Piek; P Simioni; M Caldin
Journal:  J Vet Intern Med       Date:  2016-11-16       Impact factor: 3.333

9.  Hemostatic findings of pleural fluid in dogs and the association between pleural effusions and primary hyperfibrino(geno)lysis: A cohort study of 99 dogs.

Authors:  Andrea Zoia; Michele Drigo; Christine J Piek; Paolo Simioni; Marco Caldin
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

10.  Human plasma enhances the expression of Staphylococcal microbial surface components recognizing adhesive matrix molecules promoting biofilm formation and increases antimicrobial tolerance In Vitro.

Authors:  Anthony P Cardile; Carlos J Sanchez; Meghan E Samberg; Desiree R Romano; Sharanda K Hardy; Joseph C Wenke; Clinton K Murray; Kevin S Akers
Journal:  BMC Res Notes       Date:  2014-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.